FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for Octreotide acetate submitted by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Esophageal Variceal Bleeding
• Neuroendocrine Tumor
• Vipoma

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)